e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 9

Dasatinib and quercetin senolytic treatment delays early onset intervertebral disc degeneration in SM/J mice

Emanuel J. Novais; Olivia K. Ottone; Sanjana Jagannath; Esther Jesutofunmi Akande; Ruteja A. Barve; Makarand V. Risbud · 2026 · Bone Research

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Genetic background is a major determinant of disc degeneration, a leading cause of chronic back pain and disability. Herein, we demonstrate that premature disc cell senescence contributes to early-onset degeneration in SM/J mice and test two systemic senotherapeutic strategies to mitigate it: Navitoclax (Nav.) and a cocktail of Dasatinib and Quercetin (DQ). While Nav. treatment did not improve severe degeneration in SM/J mice or senescence status, DQ-treated mice showed lower grades of degeneration and a decreased abundance of senescence markers, including p19ARF, p21, and the senescence-assoc

Abstract by Emanuel J. Novais; Olivia K. Ottone; Sanjana Jagannath; Esther Jesutofunmi Akande; Ruteja A. Barve; Makarand V. Risbud, Bone Research (2026) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1038/s41413-026-00526-4